Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography in patients with small cell lung cancer
ANNALS OF NUCLEAR MEDICINE, vol.25, no.6, pp.406-413, 2011 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 25 Issue: 6
- Publication Date: 2011
- Doi Number: 10.1007/s12149-011-0478-y
- Journal Name: ANNALS OF NUCLEAR MEDICINE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.406-413
- Keywords: FDG-PET, Small cell lung cancer, Staging, Quantitative PET
- Hacettepe University Affiliated: No
Abstract
The objective of this study is to determine whether 2-deoxy-2-[18F] fluoro-d-glucose with positron emission tomography (FDG-PET) imaging and quantitative PET parameters can predict outcome and differentiate patients with limited disease (LD) from extensive disease (ED) in patients with small cell lung cancer (SCLC).